INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Accessibility

More about accessibility

Trouble using our website?
Contact us

Text logo ERN-EYE Tools
CPMS REDgistry Elearning Members area
Accessibility

ASCENT

In this page

Clinical Trial

NCT05407636 Recruiting, Active
ASCENT

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (ASCENT)

Phase 3
Interventional

Disease

Orphan drug recognition

Yes

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

28/12/2021

Closing date

30/11/2025

Inclusion criteria :

More

Exclusion criteria :

More

Funding

Private

ERN EYE member investigating site

HCP : Principal investigators

More